Heart surgery showdown: which solution saves more heart muscle?

NCT ID NCT07637266

Recruiting now Knowledge-focused Sponsor: Klinički Bolnički Centar Zagreb Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares two solutions used to protect the heart during coronary artery bypass surgery: standard blood cardioplegia and del Nido cardioplegia. Researchers will use MRI scans to see which solution better preserves heart muscle. The trial involves 60 adults with multivessel coronary artery disease scheduled for elective bypass surgery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Del Nido cardioplegia solution and blood cardioplegia solution
What this could lead to: If one solution proves better, it could guide surgeons toward a safer method for protecting the heart during bypass surgery.
What could go wrong: This is a small, early-stage study with only 60 patients, so results may not apply to everyone. The main goal is to gather knowledge, not to prove a new treatment works.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CABG are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

coronary artery disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CABG MYOCARDIAL VIABILITY

Contacts and locations

Locations

University Hospital Center Zagreb
RECRUITING

Zagreb, 10000, Croatia
University Hospital Center Zagreb
RECRUITING

Zagreb, 10000, Croatia

More trials for these conditions

Other studies related to the condition(s) this trial covers.